Published in Radiology on January 21, 2009
A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch Neurol (2010) 3.52
Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer's disease. NMR Biomed (2010) 1.85
Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease. Neurology (2011) 1.81
Functional connectivity mapping of the human precuneus by resting state fMRI. Neuroimage (2011) 1.80
Identification of MCI individuals using structural and functional connectivity networks. Neuroimage (2011) 1.77
MRI predictors of cognitive change in a diverse and carefully characterized elderly population. Neurobiol Aging (2010) 1.56
Age-associated reductions in cerebral blood flow are independent from regional atrophy. Neuroimage (2010) 1.55
Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease. J Alzheimers Dis (2010) 1.48
Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease. Alzheimers Dement (2011) 1.41
Distinct cerebral perfusion patterns in FTLD and AD. Neurology (2010) 1.38
Latent feature representation with stacked auto-encoder for AD/MCI diagnosis. Brain Struct Funct (2013) 1.16
Group-constrained sparse fMRI connectivity modeling for mild cognitive impairment identification. Brain Struct Funct (2013) 1.15
Hierarchical feature representation and multimodal fusion with deep learning for AD/MCI diagnosis. Neuroimage (2014) 1.13
Effects of hypoperfusion in Alzheimer's disease. J Alzheimers Dis (2011) 1.13
Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions. Curr Opin Neurol (2012) 1.08
Joint analysis of structural and perfusion MRI for cognitive assessment and classification of Alzheimer's disease and normal aging. Neuroimage (2010) 1.07
Regional cerebral perfusion in patients with Alzheimer's disease and mild cognitive impairment: effect of APOE epsilon4 allele. Neuroradiology (2012) 1.07
Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition. J Cereb Blood Flow Metab (2012) 1.05
Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured by pulsed arterial spin labeling MRI. Eur Arch Psychiatry Clin Neurosci (2011) 1.03
Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice. Acta Neuropathol (2011) 1.02
Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease. Cereb Cortex (2012) 1.01
Supervised Discriminative Group Sparse Representation for Mild Cognitive Impairment Diagnosis. Neuroinformatics (2015) 1.01
Interaction of age and APOE genotype on cerebral blood flow at rest. J Alzheimers Dis (2013) 1.00
Global brain hypoperfusion and oxygenation in amnestic mild cognitive impairment. Alzheimers Dement (2013) 0.99
Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia. J Cereb Blood Flow Metab (2010) 0.97
Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease. J Alzheimers Dis (2014) 0.96
Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study. J Alzheimers Dis (2012) 0.96
Interactive effects of vascular risk burden and advanced age on cerebral blood flow. Front Aging Neurosci (2014) 0.95
Magnetoencephalography as a putative biomarker for Alzheimer's disease. Int J Alzheimers Dis (2011) 0.94
Reliability of two-dimensional and three-dimensional pseudo-continuous arterial spin labeling perfusion MRI in elderly populations: comparison with 15O-water positron emission tomography. J Magn Reson Imaging (2013) 0.94
Manifold regularized multitask feature learning for multimodality disease classification. Hum Brain Mapp (2014) 0.93
Transcranial doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer's disease. Alzheimers Dement (2011) 0.93
Initial experience in using continuous arterial spin-labeled MR imaging for early detection of Alzheimer disease. AJNR Am J Neuroradiol (2010) 0.92
Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. Brain (2014) 0.91
Changes in brain β-amyloid deposition and aquaporin 4 levels in response to altered agrin expression in mice. J Neuropathol Exp Neurol (2011) 0.90
State-of-the-art MRI techniques in neuroradiology: principles, pitfalls, and clinical applications. Neuroradiology (2015) 0.90
Non-signalling energy use in the brain. J Physiol (2015) 0.89
Distinct perfusion patterns in Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies. Eur Radiol (2014) 0.89
Increased functional connectivity within medial temporal lobe in mild cognitive impairment. Hippocampus (2012) 0.88
Perfusion MRI: the five most frequently asked clinical questions. AJR Am J Roentgenol (2013) 0.88
Cerebrovascular disease in ageing and Alzheimer's disease. Acta Neuropathol (2015) 0.87
Regional correlation between resting state FDG PET and pCASL perfusion MRI. J Cereb Blood Flow Metab (2013) 0.86
Basal and hypercapnia-altered cerebrovascular perfusion predict mild cognitive impairment in aging rodents. Neuroscience (2009) 0.86
Cerebral blood flow is an earlier indicator of perfusion abnormalities than cerebral blood volume in Alzheimer's disease. J Cereb Blood Flow Metab (2014) 0.86
Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin? Eur Radiol (2015) 0.86
Microvascular perfusion based on arterial spin labeled perfusion MRI as a measure of vascular risk in Alzheimer's disease. J Alzheimers Dis (2012) 0.85
EEG upper/low alpha frequency power ratio relates to temporo-parietal brain atrophy and memory performances in mild cognitive impairment. Front Aging Neurosci (2013) 0.85
Quantitative analysis of arterial spin labeling FMRI data using a general linear model. Magn Reson Imaging (2010) 0.85
Neuroanatomy of a neurobehavioral disturbance in the left anterior thalamic infarction. J Neurol Neurosurg Psychiatry (2011) 0.84
Arterial spin labeled MRI in prodromal Alzheimer's disease: A multi-site study. Neuroimage Clin (2013) 0.84
Constrained sparse functional connectivity networks for MCI classification. Med Image Comput Comput Assist Interv (2012) 0.84
Impaired Aβ clearance: a potential link between atherosclerosis and Alzheimer's disease. Front Aging Neurosci (2015) 0.84
MRI patterns of atrophy and hypoperfusion associations across brain regions in frontotemporal dementia. Neuroimage (2011) 0.83
A neuroradiologist's guide to arterial spin labeling MRI in clinical practice. Neuroradiology (2015) 0.82
Cerebral perfusion in the predementia stages of Alzheimer's disease. Eur Radiol (2015) 0.81
Multimodal MRI-based Imputation of the Aβ+ in Early Mild Cognitive Impairment. Ann Clin Transl Neurol (2014) 0.81
Cerebral perfusion alterations and cerebral amyloid in autosomal dominant Alzheimer disease. Neurology (2014) 0.81
Pattern of cerebral hyperperfusion in Alzheimer's disease and amnestic mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging: initial experience. Clin Interv Aging (2014) 0.80
Patterns of compensation and vulnerability in normal subjects at risk of Alzheimer's disease. J Alzheimers Dis (2013) 0.80
Distinct medial temporal contributions to different forms of recognition in amnestic mild cognitive impairment and Alzheimer's disease. Neuropsychologia (2013) 0.80
Mild cognitive impairment. Continuum (Minneap Minn) (2013) 0.79
Brain imaging of neurovascular dysfunction in Alzheimer's disease. Acta Neuropathol (2016) 0.79
Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients. J Cereb Blood Flow Metab (2016) 0.79
Pathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease. Brain Pathol (2015) 0.79
Biochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's disease. PLoS One (2014) 0.78
Asymmetric cerebral blood flow in patients with mild cognitive impairment: possible relationship to further cognitive deterioration. Dement Geriatr Cogn Dis Extra (2011) 0.78
A brain stress test: Cerebral perfusion during memory encoding in mild cognitive impairment. Neuroimage Clin (2016) 0.77
Posterior Cingulate Lactate as a Metabolic Biomarker in Amnestic Mild Cognitive Impairment. Biomed Res Int (2015) 0.77
Sparse multivariate autoregressive modeling for mild cognitive impairment classification. Neuroinformatics (2014) 0.77
The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease. Cell Mol Neurobiol (2016) 0.77
Determination of the rCBF in the amygdala and rhinal cortex using a FAIR-TrueFISP sequence. Korean J Radiol (2011) 0.76
Potential pitfall of reduced cerebral perfusion in clinical resting state functional MR imaging. Radiology (2011) 0.75
Cardiometabolic risk factors predict cerebrovascular health in older adults: results from the Brain in Motion study. Physiol Rep (2016) 0.75
Hemodynamic effects of combined focal cerebral ischemia and amyloid protein toxicity in a rat model: a functional CT study. PLoS One (2014) 0.75
Cerebral Blood Flow and Amyloid-β Interact to Affect Memory Performance in Cognitively Normal Older Adults. Front Aging Neurosci (2017) 0.75
Discriminative multi-task feature selection for multi-modality classification of Alzheimer's disease. Brain Imaging Behav (2016) 0.75
Vascular risk factors, cerebrovascular reactivity, and the default-mode brain network. Neuroimage (2015) 0.75
Voxel-wise correlations between cognition and cerebral blood flow using arterial spin-labeled perfusion MRI in patients with Alzheimer's disease: a cross-sectional study. BMC Neurol (2017) 0.75
Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease. Eur Radiol (2016) 0.75
[New perspectives on Alzheimer's disease from neuroimaging]. Rev Neurol (2010) 0.75
Compensatory functional reorganization may precede hypertension-related brain damage and cognitive decline: a functional magnetic resonance imaging study. J Hypertens (2017) 0.75
Longitudinal imaging reveals subhippocampal dynamics in glutamate levels associated with histopathologic events in a mouse model of tauopathy and healthy mice. Hippocampus (2017) 0.75
Regional Cerebral Blood Flow in Mild Cognitive Impairment and Alzheimer's Disease Measured with Arterial Spin Labeling Magnetic Resonance Imaging. Int J Alzheimers Dis (2017) 0.75
Brain Regional Blood Flow and Working Memory Performance Predict Change in Blood Pressure Over 2 Years. Hypertension (2017) 0.75
Optimization of brain perfusion image quality by cortical surface-based projection of arterial spin labeling maps in early-onset Alzheimer's disease patients. Eur Radiol (2015) 0.75
Comparison of PASL, PCASL, and background-suppressed 3D PCASL in mild cognitive impairment. Hum Brain Mapp (2017) 0.75
Changes of EEG Spectra and Functional Connectivity during an Object-Location Memory Task in Alzheimer's Disease. Front Behav Neurosci (2017) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry (1987) 19.45
[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology (2006) 12.10
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol (1997) 10.06
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology (1999) 9.86
Frontal-subcortical circuits and human behavior. Arch Neurol (1993) 5.61
Modeling the hemodynamic response to brain activation. Neuroimage (2004) 5.15
Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci U S A (1985) 4.97
Detecting activations in PET and fMRI: levels of inference and power. Neuroimage (1996) 4.86
Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol (2003) 4.82
Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology (2006) 4.06
Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology (2005) 3.90
Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology (2003) 3.60
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging (2003) 3.50
Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage (2005) 3.28
Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage (2004) 3.25
Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology (2005) 3.14
Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage (2002) 3.06
Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. Radiology (1998) 2.73
A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage (2003) 2.67
Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment. Neuroimage (2005) 2.51
Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol (2001) 2.51
Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol (2000) 2.35
Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study. Arch Neurol (2007) 2.35
Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann Neurol (2003) 2.26
Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease. Ann Neurol (2008) 2.24
Perfusion fMRI detects deficits in regional CBF during memory-encoding tasks in MCI subjects. Neurology (2007) 2.09
Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images. AJNR Am J Neuroradiol (2005) 1.97
A theoretical and experimental comparison of continuous and pulsed arterial spin labeling techniques for quantitative perfusion imaging. Magn Reson Med (1998) 1.93
In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology (1999) 1.86
Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease. Neurology (2006) 1.85
Effects of aging on cerebral blood flow, oxygen metabolism, and blood oxygenation level dependent responses to visual stimulation. Hum Brain Mapp (2009) 1.82
Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease. Brain (2002) 1.81
Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology (1994) 1.67
Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment. Arch Neurol (2006) 1.65
The accumbens: beyond the core-shell dichotomy. J Neuropsychiatry Clin Neurosci (1997) 1.63
Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer's disease. Neurology (1996) 1.55
A comparison between the accuracy of voxel-based morphometry and hippocampal volumetry in Alzheimer's disease. J Magn Reson Imaging (2004) 1.54
Hippocampal hyperperfusion in Alzheimer's disease. Neuroimage (2008) 1.49
Measurement of cerebral perfusion with arterial spin labeling: Part 1. Methods. J Int Neuropsychol Soc (2007) 1.46
Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B. J Neurosci Methods (2008) 1.46
The concepts of the ventral striatopallidal system and extended amygdala. Ann N Y Acad Sci (1999) 1.43
Measurement of cerebral perfusion with arterial spin labeling: Part 2. Applications. J Int Neuropsychol Soc (2007) 1.42
Cerebral glucose metabolism in patients with AD and different APOE genotypes. Neurology (2005) 1.33
Event-related functional magnetic resonance imaging investigation of executive control in very old individuals with mild cognitive impairment. Biol Psychiatry (2005) 1.28
Different brain networks mediate task performance in normal aging and AD: defining compensation. Neurology (2000) 1.28
SPECT perfusion imaging in the diagnosis of Alzheimer's disease: a clinical-pathologic study. Neurology (2001) 1.27
Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging. Neuroimage (2007) 1.04
Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease. J Psychiatr Res (1999) 1.03
Simple model of double adiabatic inversion (DAI) efficiency. Magn Reson Med (2004) 0.99
Human striatum: chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease. Neuroscience (1994) 0.87
Functional MRI using steady-state arterial water labeling. Magn Reson Med (1998) 0.85
Effects of image normalization on the statistical analysis of perfusion MRI in elderly brains. J Magn Reson Imaging (2008) 0.80
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Estrogen therapy and coronary-artery calcification. N Engl J Med (2007) 8.70
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA (2010) 7.12
Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 6.51
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA (2008) 6.00
HIV infection and the risk of acute myocardial infarction. JAMA Intern Med (2013) 5.90
Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis (2010) 5.35
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimers Dement (2010) 4.85
Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol (2003) 4.82
Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med (2009) 4.80
Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS One (2012) 3.68
Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry (2006) 3.61
Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial. Lancet Oncol (2012) 3.56
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol (2007) 3.55
Thyroid status, cardiovascular risk, and mortality in older adults. JAMA (2006) 3.50
Estrogen plus progestin and risk of venous thrombosis. JAMA (2004) 3.46
Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc (2004) 3.43
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. Am J Epidemiol (2009) 3.33
Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA (2006) 3.26
Association between lower digit symbol substitution test score and slower gait and greater risk of mortality and of developing incident disability in well-functioning older adults. J Am Geriatr Soc (2008) 3.21
Evaluation of dementia in the cardiovascular health cognition study. Neuroepidemiology (2003) 3.19
The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry (2004) 3.17
Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am J Epidemiol (2005) 3.10
Optimism, cynical hostility, and incident coronary heart disease and mortality in the Women's Health Initiative. Circulation (2009) 3.09
Research evaluation and prospective diagnosis of dementia with Lewy bodies. Arch Neurol (2002) 3.07
Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc (2005) 3.07
The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease. Am J Psychiatry (2013) 3.06
Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study. Am J Epidemiol (2008) 3.05
Brain structure and obesity. Hum Brain Mapp (2010) 3.04
Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 2.97
Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology (2003) 2.97
Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation (2007) 2.93
Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation (2003) 2.88
Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care (2007) 2.87
Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst (2011) 2.84
Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol (2003) 2.83
n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am J Clin Nutr (2003) 2.82
Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proc Natl Acad Sci U S A (2005) 2.79
Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol (2009) 2.79
Estrogen plus progestin therapy and breast cancer in recently postmenopausal women. Am J Epidemiol (2008) 2.79
Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J Am Coll Cardiol (2008) 2.74
Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch Neurol (2003) 2.70
Extent of cardiovascular risk reduction associated with treatment of isolated systolic hypertension. Arch Intern Med (2003) 2.69
3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry. Neuroimage (2006) 2.69
Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care (2009) 2.68
Dementia with Lewy bodies. Lancet Neurol (2004) 2.66
Amyloid imaging in mild cognitive impairment subtypes. Ann Neurol (2009) 2.66
Adiponectin and risk of coronary heart disease in older men and women. J Clin Endocrinol Metab (2008) 2.65
Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA (2009) 2.59
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58
Beta2-adrenergic receptor genetic variants and risk of sudden cardiac death. Circulation (2006) 2.57
Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab (2003) 2.56
Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment. Neuroimage (2005) 2.51
C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation (2005) 2.48
High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey. Cancer Epidemiol Biomarkers Prev (2002) 2.46
Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial. Hypertension (2008) 2.44
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol (2011) 2.37
Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study. Arch Neurol (2007) 2.35
Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study. Diabetes Care (2007) 2.33
Statistical properties of Jacobian maps and the realization of unbiased large-deformation nonlinear image registration. IEEE Trans Med Imaging (2007) 2.33
Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med (2008) 2.32
Subclinical brain magnetic resonance imaging abnormalities predict physical functional decline in high-functioning older adults. J Am Geriatr Soc (2005) 2.31
Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci (2008) 2.30
Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry (2006) 2.29
Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J (2013) 2.21
Comparison of HOMA-IR, HOMA-β% and disposition index between US white men and Japanese men in Japan: the ERA JUMP study. Diabetologia (2014) 2.21
Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection. J Acquir Immune Defic Syndr (2011) 2.21
Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis (2009) 2.20
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology (2012) 2.19
Depressive symptoms and stressful life events predict metabolic syndrome among middle-aged women: a comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions. Diabetes Care (2007) 2.16
Racial differences in coronary artery calcification in older adults. Arterioscler Thromb Vasc Biol (2002) 2.15
Racial differences in glycemic control in a well-functioning older diabetic population: findings from the Health, Aging and Body Composition Study. Diabetes Care (2003) 2.14
Glucose, blood pressure, and lipid control in older people with and without diabetes mellitus: the Cardiovascular Health Study. J Am Geriatr Soc (2002) 2.13
A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A (2010) 2.12